EICHORCondition: Carcinoma, Renal Cell · Sponsor: Merck Sharp & Dohme LLC
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Researchers are looking for new ways to treat advanced renal cell carcinoma (RCC). A standard (usual) treatment for certain people with RCC is belzutifan (a study medicine), which is a targeted therapy. Targeted therapy is a treatment that works to control how specific types of cancer cells grow and spread. Researchers want to learn if adding another targeted therapy called zanzalintinib (another study medicine) can treat more people with advanced RCC than belzutifan alone. The goal of this study is to learn if people who receive belzutifan and zanzalintinib live longer overall and without the cancer getting worse compared to people who receive belzutifan and placebo.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) | Marietta, Georgia, United States | Recruiting |
| The West Clinic, P.C. ( Site 0115) | Germantown, Tennessee, United States | Recruiting |
| Centro Oncologico Korben ( Site 0254) | CABA, Buenos Aires, Argentina | Recruiting |
| Hospital Italiano de Buenos Aires ( Site 0253) | Ciudad de Buenos Aires, Buenos Aires, Argentina | Recruiting |
| Instituto de Investigaciones Clinicas Mar del Plata ( Site 0250) | Mar del Plata, Buenos Aires, Argentina | Recruiting |
| Centro Privado de RMI Río Cuarto S.A. II ( Site 0255) | Río Cuarto, Córdoba Province, Argentina | Recruiting |
| Sanatorio Parque ( Site 0251) | Rosario, Santa Fe Province, Argentina | Recruiting |
| Instituto de Oncología de Rosario ( Site 0257) | Rosario, Santa Fe Province, Argentina | Recruiting |
| Instituto Alexander Fleming ( Site 0252) | CABA, Argentina | Recruiting |
| Centro Oncológico Riojano Integral ( Site 0256) | La Rioja, Argentina | Recruiting |
| COE (Centro Oncológico de Excelencia) ( Site 0259) | San Juan, Argentina | Recruiting |
| Macquarie University ( Site 2700) | Macquarie University, New South Wales, Australia | Suspended |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07489495